A gene deletion is reported to make colon cancer more susceptible to immunotherapy. However, other outlets are not covering this story, instead reporting on unrelated topics such as conflict in Crimea, CRISPR technology, Kabuki syndrome, and multiple sclerosis. The connection between the gene deletion and colon cancer treatment is not confirmed by these other outlets, which appear to be covering separate stories.